05:48 PM EST, 01/21/2025 (MT Newswires) -- Phio Pharmaceuticals ( PHIO ) late Tuesday filed a registration statement with US Securities Exchange Commission for the resale of up to about 5.9 million shares by its shareholders.

The prospectus coverage includes up to 437,192 shares issuable on exercise of series E warrants and up to 240,000 shares on exercise of series F warrants, according to the filing.